3,4-dihydrospiro[1-benzopyran-2,1-cyclobutane]-4-amine
- $330 - $921
- Product name: 3,4-dihydrospiro[1-benzopyran-2,1-cyclobutane]-4-amine
- CAS: 934554-38-8
- MF: C12H15NO
- MW: 189.25
- EINECS:
- MDL Number:MFCD20694742
- Synonyms:3,4-dihydrospiro[1-benzopyran-2,1-cyclobutane]-4-amine;Spiro[2H-1-benzopyran-2,1'-cyclobutan]-4-amine, 3,4-dihydro-
4 prices
Selected condition:
Brand
- American Custom Chemicals Corporation
- Chemenu
- Crysdot
- TRC
Package
- 5MG
- 100mg
- 1g
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberCHM1050889
- Product description3,4-DIHYDROSPIRO[1-BENZOPYRAN-2,1'-CYCLOBUTANE]-4-AMINE 95.00%
- Packaging5MG
- Price$495.07
- Updated2021-12-16
- Buy
- ManufacturerChemenu
- Product numberCM219130
- Product descriptionSpiro[chroman-2,1''-cyclobutan]-4-amine 95+%
- Packaging1g
- Price$869
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11009914
- Product descriptionSpiro[chroman-2,1'-cyclobutan]-4-amine 97%
- Packaging1g
- Price$921
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberD457980
- Product description3,4-dihydrospiro[1-benzopyran-2,1''-cyclobutane]-4-amine
- Packaging100mg
- Price$330
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
American Custom Chemicals Corporation | CHM1050889 | 3,4-DIHYDROSPIRO[1-BENZOPYRAN-2,1'-CYCLOBUTANE]-4-AMINE 95.00% | 5MG | $495.07 | 2021-12-16 | Buy |
Chemenu | CM219130 | Spiro[chroman-2,1''-cyclobutan]-4-amine 95+% | 1g | $869 | 2021-12-16 | Buy |
Crysdot | CD11009914 | Spiro[chroman-2,1'-cyclobutan]-4-amine 97% | 1g | $921 | 2021-12-16 | Buy |
TRC | D457980 | 3,4-dihydrospiro[1-benzopyran-2,1''-cyclobutane]-4-amine | 100mg | $330 | 2021-12-16 | Buy |
Properties
Safety Information
Symbol(GHS): | ||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Signal word: | Danger | |||||||||||||||||||||||||||||||||||
Hazard statements: |
|
|||||||||||||||||||||||||||||||||||
Precautionary statements: |
|